Bullish on Lupin: Ashwani Gujral

Ashwani Gujral, Chief Market Strategist, ashwanigujral.com, in a chat with ET Now, gives his views on pharma stocks


Any stock from the pharma pack that has caught your eye?

Lupin obviously is outperforming and likely to get up to Rs 510. Ranbaxy has also moved into some support zone. These stocks may fall less but does not look like anything is going to run up significantly. So maybe Ranbaxy with a stop of about Rs 480 you could look at levels of Rs 550. If the market stabilises, probably this space is the one which will rally first but if we remain subdued, then these stocks are likely to move sideways.